{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:01:52Z","timestamp":1787162512871,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015960","name":"Dipartimento di Biologia e Biotecnologie L. Spallanzani, Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.09.070","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T02:46:24Z","timestamp":1539398784000},"page":"239-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-732X","authenticated-orcid":false,"given":"Claudia","family":"Mugnaini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-7077","authenticated-orcid":false,"given":"Alessandro","family":"Rabbito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Brizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastasja","family":"Palombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ligresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-4504","authenticated-orcid":false,"given":"Federico","family":"Corelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.09.070_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.09.070_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.09.070_bib4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1189\/jlb.0405216","article-title":"Cannabinoid receptors in microglia of the central nervous system: immune functional relevance","volume":"78","author":"Cabral","year":"2005","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib5","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/cbdv.200790154","article-title":"Discovery and isolation of anandamide and other endocannabinoids","volume":"4","author":"Hanus","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2018.09.070_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4149\/endo_2012_02_107","article-title":"The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview","volume":"46","author":"Barna","year":"2012","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.ejmech.2018.09.070_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.09.070_bib9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/138945012800675786","article-title":"The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke","volume":"13","author":"Pini","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2018.09.070_bib10a","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/j.pain.0000000000000132","article-title":"A\u00a0multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis","volume":"156","author":"Malek","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2018.09.070_bib10b","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/wmts.83","article-title":"Cannabinoid receptors and pain","volume":"2","author":"Starowicz","year":"2013","journal-title":"WIREs Membr. Transp. Signal."},{"key":"10.1016\/j.ejmech.2018.09.070_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11539000-000000000-00000","article-title":"Role of cannabinoids in multiple sclerosis","volume":"25","author":"Zaiicek","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2018.09.070_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10555-011-9318-8","article-title":"Cannabinoids, endocannabinoids and cancer","volume":"30","author":"Hermanson","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2018.09.070_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signaling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2018.09.070_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"Medicinal chemistry, pharmacology, and therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Tabrizi","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.09.070_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000455916","article-title":"The inhibitory effect of S-777469, a cannabinoid type 2 receptor agonist, on skin inflammation in mice","volume":"99","author":"Haruna","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2018.09.070_bib17","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals signalling and off-target activity","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2018.09.070_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/13543776.2016.1193157","article-title":"Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update","volume":"26","author":"Morales","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2018.09.070_bib19a","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/jm800552f","article-title":"Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in\u00a0vivo","volume":"51","author":"Pasquini","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib19b","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1021\/jm200476p","article-title":"Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and anti-hyperalgesic effects in mice","volume":"54","author":"Pasquini","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib19c","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/acs.jmedchem.5b01559","volume":"59","author":"Mugnaini","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2016.12.009","article-title":"Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis","volume":"303","author":"Annunziata","year":"2017","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.phrs.2012.08.003","article-title":"A\u00a0novel substituted 4-quinolone-3-carboxylic acid derivative CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury","volume":"66","author":"Contartese","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.09.070_bib22","doi-asserted-by":"crossref","first-page":"349354","DOI":"10.1016\/j.phrs.2009.11.011","article-title":"In\u00a0vitro and in\u00a0vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists","volume":"61","author":"Cascio","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.09.070_bib23a","doi-asserted-by":"crossref","first-page":"31417","DOI":"10.1039\/C7RA04808D","article-title":"Synthesis and in\u00a0vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2","volume":"7","author":"Bozorov","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.09.070_bib23b","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejmech.2013.11.031","article-title":"Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold","volume":"73","author":"Hrast","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib23c","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1021\/jm401560v","article-title":"Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly","volume":"56","author":"Massari","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib23d","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.bmcl.2012.01.121","article-title":"Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management","volume":"22","author":"Nelson","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.09.070_bib23e","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1016\/j.bmcl.2012.10.087","article-title":"Structure-activity relationships of 2-arylamido-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide derivatives as cannabinoid receptor agonists and their analgesic action","volume":"22","author":"Thur","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.09.070_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.111.186460","article-title":"Characterization of methyl 2-(adamantan-1-yl-carboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexylcarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), two novel positive allosteric modulators of the GABAB receptor","volume":"340","author":"Castelli","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.070_bib25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1039\/C3RA45546G","article-title":"Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof","volume":"4","author":"Mugnaini","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.09.070_bib26","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1021\/jm400144w","article-title":"Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor","volume":"56","author":"Mugnaini","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2016.07.012","article-title":"Discovery of novel tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: the structural elements controlling binding affinity, selectivity and functionality","volume":"122","author":"Osman","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00243","article-title":"CB2 cannabinoid receptors as potential target against Alzheimer's disease","volume":"10","author":"Aso","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2018.09.070_bib29a","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00350","article-title":"Synthesis and biological evaluation of thiophene-based cannabinoid receptor type 2 radiotracers for PET imaging","volume":"10","author":"Haider","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2018.09.070_bib29b","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1021\/acs.jmedchem.6b00554","article-title":"Development of a high-affinity PET radioligand for imaging cannabinoid subtype 2 receptor","volume":"59","author":"Moldovan","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib29c","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/acs.jmedchem.5b00283","article-title":"Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor","volume":"58","author":"Slavik","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acs.jmedchem.6b01437","article-title":"Recent advances in scaffold hopping","volume":"60","author":"Hu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib31","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1021\/jo990903e","article-title":"Improved syntheses of 3H,5H-pyrrolo[3,2-d]pyrimidines","volume":"64","author":"Furneaux","year":"1999","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib32","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.tetlet.2009.02.223","article-title":"Methylation of 4-nitro-3(5)-pyrazolecarboxylic acid","volume":"50","author":"Regiec","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.09.070_bib33","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1246\/bcsj.42.1653","article-title":"Reactions of \u03b1-cyano-\u03b2-methoxy-\u03b2-alkylacrylic esters with hydrazine and hydroxylamine","volume":"42","author":"Baba","year":"1969","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2018.09.070_bib34","unstructured":"Regiec, A.; Gadzinski, P.; Ploszaj, P. New Methods for Preparing of Esters of 5-amino-3-methyl-4-isoxazolecarboxylic Acid. PL 216764 B1 20140530."},{"key":"10.1016\/j.ejmech.2018.09.070_bib35a","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","article-title":"SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi-Carmona","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.070_bib35b","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630","volume":"126","author":"Ross","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib36","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/acs.jmedchem.5b01501","article-title":"The importance of being Me: magic methyls, methyltransferase inhibitors, and the discovery of tazemetostat","volume":"59","author":"Kuntz","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib37","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1021\/cr200060g","article-title":"The methylation effect in medicinal chemistry","volume":"111","author":"Barreiro","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.09.070_bib38","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1021\/jm3003697","article-title":"Methyl effects on protein-ligand binding","volume":"55","author":"Leung","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib39","unstructured":"Calculated with Molinspiration Cheminformatics Software (www.molinspiration.com)."},{"key":"10.1016\/j.ejmech.2018.09.070_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-0-387-72005-0_43","article-title":"Therapeutic potential of cannabinoid-based drugs","volume":"601","author":"Klein","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2018.09.070_bib41","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","article-title":"Attenuation of allergic contact dermatitis through the endocannabinoid system","volume":"316","author":"Karsak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.09.070_sref32","unstructured":"(Reviews):"},{"key":"10.1016\/j.ejmech.2018.09.070_bib42a","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01961779408048964","article-title":"The Gewald synthesis","volume":"16","author":"Sabnis","year":"1994","journal-title":"Sulfur Rep."},{"key":"10.1016\/j.ejmech.2018.09.070_bib42b","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jhet.5570360203","article-title":"2-Aminothiophenes by the Gewald reaction","volume":"36","author":"Sabnis","year":"1999","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.09.070_bib42c","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11030-010-9229-6","article-title":"The Gewald multicomponent reaction","volume":"15","author":"Huang","year":"2011","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2018.09.070_bib43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1398-9995.2009.02254.x","article-title":"Protective role of palmitoylethanolamide in contact allergic dermatitis","volume":"65","author":"Petrosino","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2018.09.070_bib44","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:48:05Z","timestamp":1759326485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418308572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":57,"alternative-id":["S0223523418308572"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.070","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}